Effect of splenectomy on destructive bone changes in children with chronic (Type I) Gaucher disease
- PMID: 3732318
- DOI: 10.1007/BF00441877
Effect of splenectomy on destructive bone changes in children with chronic (Type I) Gaucher disease
Abstract
The incidence and severity of osteolytic bone changes in patients with chronic (Type I) Gaucher disease splenectomized in the first decade of life were compared to those in patients of the same age group and similar degree of severity of the disease in whom the spleen remained intact at least until the second half of the second decade. The size of the spleen, measured by palpation, was used as an index of severity. In the splenectomized group osteolytic changes appeared within a few months following splenectomy in six out of eight cases. The changes were severe in five cases and moderate in one. In contrast, in the non-splenectomized group, evidence of bone destruction was found in two out of eight patients and classified as mild in both cases. Furthermore, in three patients in this group, who remained free of bone destruction until splenectomy in the second half of the second decade, osteolytic lesions appeared soon after the operation. Children with chronic Gaucher disease can be spared a great deal of suffering caused by bone disease, if splenectomy is avoided or postponed as far as possible.
Similar articles
-
Gaucher disease--Norrbottnian type (III). Neuropaediatric and neurobiological aspects of clinical patterns and treatment.Acta Paediatr Scand Suppl. 1986;326:1-42. Acta Paediatr Scand Suppl. 1986. PMID: 3296644
-
Hematological findings in the Norrbottnian type of Gaucher disease.Eur J Pediatr. 1982 Nov;139(3):187-91. doi: 10.1007/BF01377354. Eur J Pediatr. 1982. PMID: 7160406
-
Severe skeletal complications in Japanese patients with type 1 Gaucher disease.J Inherit Metab Dis. 1999 Feb;22(1):63-73. doi: 10.1023/a:1005451300167. J Inherit Metab Dis. 1999. PMID: 10070619
-
[Treatment of Gaucher disease with allogeneic hematopoietic stem cell transplantation: report of three cases and review of literatures].Zhonghua Er Ke Za Zhi. 2015 Nov;53(11):810-6. Zhonghua Er Ke Za Zhi. 2015. PMID: 26758318 Review. Chinese.
-
Gaucher disease: pediatric concerns.Paediatr Drugs. 2002;4(7):417-26. doi: 10.2165/00128072-200204070-00001. Paediatr Drugs. 2002. PMID: 12083970 Review.
Cited by
-
Life expectancy in Gaucher disease type 1.Am J Hematol. 2008 Dec;83(12):896-900. doi: 10.1002/ajh.21305. Am J Hematol. 2008. PMID: 18980271 Free PMC article.
-
Revised recommendations for the management of Gaucher disease in children.Eur J Pediatr. 2013 Apr;172(4):447-58. doi: 10.1007/s00431-012-1771-z. Epub 2012 Jul 8. Eur J Pediatr. 2013. PMID: 22772880 Review.
-
Remaining problems in the management of patients with Gaucher disease.J Inherit Metab Dis. 2001;24 Suppl 2:122-6; discussion 87-8. doi: 10.1023/a:1012452715079. J Inherit Metab Dis. 2001. PMID: 11758672 Review.
-
Effective treatment of painful bone crises in type I gaucher's disease with high dose prednisolone.Arch Dis Child. 1996 Sep;75(3):218-22. doi: 10.1136/adc.75.3.218. Arch Dis Child. 1996. PMID: 8976661 Free PMC article.
-
Elective subtotal splenectomy. Indications and results in 33 patients.Ann Surg. 1990 Jan;211(1):34-42. doi: 10.1097/00000658-199001000-00006. Ann Surg. 1990. PMID: 2294841 Free PMC article.